TURNING POINT THERAPEUTICS I (TPTX) Stock Analyst Ratings
NASDAQ:TPTX - Nasdaq - US90041T1088 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 72% to TPTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 74.9. This target is -1.46% below the current price.
TPTX was analyzed by 15 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about TPTX.
In the previous month the buy percentage consensus was at a similar level.
TPTX was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-06-13 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-06-06 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2022-06-06 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-06-03 | Wedbush | Downgrade | Outperform -> Neutral |
| 2022-05-24 | Goldman Sachs | Maintains | Buy |
| 2022-05-20 | B of A Securities | Initiate | Buy |
| 2022-05-11 | SVB Leerink | Maintains | Outperform |
| 2022-03-01 | Stifel | Maintains | Hold |
| 2022-02-10 | Wells Fargo | Maintains | Overweight |
| 2022-01-21 | Oppenheimer | Maintains | Outperform |
| 2021-12-07 | Cowen & Co. | Initiate | Outperform |
| 2021-11-10 | Oppenheimer | Maintains | Outperform |
| 2021-10-12 | HC Wainwright & Co. | Maintains | Buy |
| 2021-10-11 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2021-09-30 | Stifel | Initiate | Hold |
| 2021-04-06 | HC Wainwright & Co. | Maintains | Buy |